Wijnand K. den Dekker

Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial

Roberto Diletti, Wijnand K. den Dekker, Johan Bennett et al. · The Lancet · 2023 · 157 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Randomised Trial +9

Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model

Katarína Larsen, Caroline Cheng, Dennie Tempel et al. · European Heart Journal · 2011 · 91 citations · Full text

Endothelial Cell–Specific FGD5 Involvement in Vascular Pruning Defines Neovessel Fate in Mice

Caroline Cheng, Remco Haasdijk, Dennie Tempel et al. · Circulation · 2012 · 70 citations · Full text

Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes

Roberto Diletti, Kaneshka Masdjedi, Joost Daemen et al. · Circulation Cardiovascular Interventions · 2021 · 59 citations · Full text

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients

Wijnand K. den Dekker, Jaco H. Houtgraaf, Yoshinobu Onuma et al. · Atherosclerosis · 2011 · 57 citations · Full text

Regenerative Medicine, Cell Therapy, Bio-engineered Cd34 Antibody +11